Allosteric Control of Ligand Selectivity between Estrogen Receptors α and β: Implications for Other Nuclear Receptors

Molecular Cell

Volumn 13, Issue 3, 2004, Pages 317-327

  Nettles, Kendall W ^a   Sun, Jun ^b   Radek, James T ^a   Sheng, Shubin ^b   Rodriguez, Alice L ^c   Katzenellenbogen, John A ^c   Katzenellenbogen, Benita S ^b   Greene, Geoffrey L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BINDING PROTEIN; CELL NUCLEUS RECEPTOR; CELL RECEPTOR; CHIMERIC PROTEIN; DIMER; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIGAND; PARTIAL AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RECEPTOR SUBTYPE;

ALLOSTERISM; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; ANIMAL CELL; ARTICLE; BINDING SITE; CELL COMMUNICATION; CELL NUCLEUS; CELL STRAIN COS1; CHEMICAL STRUCTURE; CHEMISTRY; CHIMERA; CONFORMATION; CONTROLLED STUDY; GENETICS; HUMAN; HUMAN CELL; LIGAND BINDING; MAMMAL CELL; METABOLISM; MOLECULAR GENETICS; MOLECULAR INTERACTION; NONHUMAN; PHYSIOLOGY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; RECEPTOR SENSITIVITY; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; TUMOR CELL LINE;

ANIMALIA; MAMMALIA;

EID: 1242294391     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(04)00054-1     Document Type: Article

References (38)

1. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell. 5:2000;289-298.
2. Bramlett K.S., Wu Y., Burris T.P. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes. Mol. Endocrinol. 15:2001;909-922.
3. Chen J.Y., Clifford J., Zusi C., Starrett J., Tortolani D., Ostrowski J., Reczek P.R., Chambon P., Gronemeyer H. Two distinct actions of retinoid-receptor ligands. Nature. 382:1996;819-822.
4. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., Fletterick R.J., Yamamoto K.R. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:1998;3343-3356.
5. DiRenzo J., Soderstrom M., Kurokawa R., Ogliastro M.H., Ricote M., Ingrey S., Horlein A., Rosenfeld M.G., Glass C.K. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol. Cell. Biol. 17:1997;2166-2176.
6. Forman B.M., Umesono K., Chen J., Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 81:1995;541-550.
7. Gaido K.W., Leonard L.S., Maness S.C., Hall J.M., McDonnell D.P., Saville B., Safe S. Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta. Endocrinology. 140:1999;5746-5753.
8. Gaido K.W., Maness S.C., McDonnell D.P., Dehal S.S., Kupfer D., Safe S. Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor. structure-activity studies Mol. Pharmacol. 58:2000;852-858.
9. Gampe R.T. Jr., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., Kliewer S.A., Willson T.M., Xu H.E. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell. 5:2000;545-555.
10. Gee A.C., Carlson K.E., Martini P.G., Katzenellenbogen B.S., Katzenellenbogen J.A. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Mol. Endocrinol. 13:1999;1912-1923.
11. Germain P., Iyer J., Zechel C., Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature. 415:2002;187-192.
12. Gupta R.A., Brockman J.A., Sarraf P., Willson T.M., DuBois R.N. Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells. J. Biol. Chem. 276:2001;29681-29687.
13. Kallenberger B.C., Love J.D., Chatterjee V.K., Schwabe J.W. A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease. Nat. Struct. Biol. 10:2003;136-140.
14. Kraichley D.M., Sun J., Katzenellenbogen J.A., Katzenellenbogen B.S. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-α and estrogen receptor-β correlations with biological character and distinct differences among SRC coactivator family members Endocrinology. 141:2000;3534-3545.
15. Lala D.S., Mukherjee R., Schulman I.G., Koch S.S., Dardashti L.J., Nadzan A.M., Croston G.E., Evans R.M., Heyman R.A. Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature. 383:1996;450-453.
16. Love J.D., Gooch J.T., Benko S., Li C., Nagy L., Chatterjee V.K., Evans R.M., Schwabe J.W. The structural basis for the specificity of retinoid-X receptor-selective agonists. new insights into the role of helix H12 J. Biol. Chem. 277:2002;11385-11391.
17. McInerney E.M., Weis K.E., Sun J., Mosselman S., Katzenellenbogen B.S. Transcription activation by the human estrogen receptor subtype beta (ER-beta) studied with ER-beta and ER-alpha receptor chimeras. Endocrinology. 139:1998;4513-4522.
18. Meyers M.J., Sun J., Carlson K.E., Katzenellenbogen B.S., Katzenellenbogen J.A. Estrogen receptor subtype-selective ligands. asymmetric synthesis and biological evaluation of cis- and trans-5, 11-dialkyl- 5,6,11,12-tetrahydrochrysenes J. Med. Chem. 42:1999;2456-2468.
19. Mukherjee R., Davies P.J., Crombie D.L., Bischoff E.D., Cesario R.M., Jow L., Hamann L.G., Boehm M.F., Mondon C.E., Nadzan A.M.et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature. 386:1997;407-410.
20. Nikolova P.V., Wong K.B., DeDecker B., Henckel J., Fersht A.R. Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations. EMBO J. 19:2000;370-378.
21. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., Milburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature. 395:1998;137-143.
22. Pike A.C., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A.G., Engstrom O., Ljunggren J., Gustafsson J., Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 18:1999;4608-4618.
23. Ray D.W., Suen C.S., Brass A., Soden J., White A. Structure/function of the human glucocorticoid receptor. tyrosine 735 is important for transactivation Mol. Endocrinol. 13:1999;1855-1863.
24. Schulman I.G., Juguilon H., Evans R.M. Activation and repression by nuclear hormone receptors. hormone modulates an equilibrium between active and repressive states Mol. Cell. Biol. 16:1996;3807-3813.
25. Schulman I.G., Li C., Schwabe J.W., Evans R.M. The phantom ligand effect. allosteric control of transcription by the retinoid X receptor Genes Dev. 11:1997;299-308.
26. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95:1998;927-937.
27. Shiau A.K., Barstad D., Radek J.L., Meyers M.J., Katzenellenbogen B.S., Katzenellenbogen J.A., Agard D.A., Greene G.L. Structural characterization of an estrogen receptor α agonist/estrogen receptor β antagonist reveals a novel mode of receptor antagonism. Nat. Struct. Biol. 9:2000;359-364.
28. Sinha N., Nussinov R. Point mutations and sequence variability in proteins. redistributions of preexisting populations Proc. Natl. Acad. Sci. USA. 98:2001;3139-3144.
29. Stauffer S.R., Coletta C.J., Tedesco R., Sun J., Katzenellenbogen B.S., Katzenellenbogen J.A. Pyrazole ligands. structure-affinity/activity relationships of estrogen receptor-α selective agonists J. Med. Chem. 43:2000;4934-4947.
30. Steinmetz A.C., Renaud J.P., Moras D. Binding of ligands and activation of transcription by nuclear receptors. Annu. Rev. Biophys. Biomol. Struct. 30:2001;329-359.
31. Stevens A., Garside H., Berry A., Waters C., White A., Ray D. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface. the role of tyrosine 735 Mol. Endocrinol. 17:2003;845-859.
32. Sun J., Meyers M.J., Fink B.E., Rajendran R., Katzenellenbogen J.A., Katzenellenbogen B.S. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β Endocrinology. 140:1999;800-804.
33. Sun J., Baudry J., Katzenellenbogen J.A., Katzenellenbogen B.S. Molecular basis for the subtype discrimination of the estrogen receptor-beta-selective ligand, diarylpropionitrile. Mol. Endocrinol. 17:2003;247-258. a.
34. Sun J., Katzenellenbogen J.A., Zhao H., Katzenellenbogen B.S. DNA shuffling method for generating estrogen receptor α and β chimeras in yeast. Biotechniques. 34:2003;278-288. b.
35. Watkins R., Davis-Searles P., Lambert M., Redinbo M. Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J. Mol. Biol. 331:2003;815-828.
36. Webb P., Nguyen P., Kushner P.J. Differential SERM effects on corepressor binding dictate ERalpha activity in vivo. J. Biol. Chem. 278:2003;6912-6920.
37. Westin S., Kurokawa R., Nolte R.T., Wisely G.B., McInerney E.M., Rose D.W., Milburn M.V., Rosenfeld M.G., Glass C.K. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature. 395:1998;199-202.
38. Wisniewski D., Lambek C.L., Liu C., Strife A., Veach D.R., Nagar B., Young M.A., Schindler T., Bornmann W.G., Bertino J.R.et al. Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. Cancer Res. 62:2002;4244-4255.